Valuation : OrganiGram

Market Cap 21Cr 15Cr 13Cr 12Cr 11Cr 1.43TCr 21Cr 144.54Cr 56Cr 725.03Cr 56Cr 55Cr 2.29TCr P/E 2026 *
1.82x
P/E 2027 * 18.4x
Enterprise Value 21Cr 15Cr 13Cr 12Cr 11Cr 1.43TCr 21Cr 144.54Cr 56Cr 725.03Cr 56Cr 55Cr 2.29TCr EV / Sales 2026 *
0.59x
EV / Sales 2027 * 0.45x
Free-Float
68.94%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 15/01/2026
Director of Finance/CFO - 08/01/2024
Chief Operating Officer - 19/08/2026
Director TitleAgeSince
Chairman 65 29/03/2018
Director/Board Member 56 17/12/2018
Director/Board Member 70 17/12/2018
Change 5-day change 1-year change 3-year change Capi.($)
-3.89%+9.83% - - 15Cr
+0.52%-1.37%+15.20%+171.70% 35Cr
0.00%-7.55%-35.81%-41.90% 15Cr
+2.30%+0.50%+16.28%+104.08% 14Cr
+6.59%+4.30%-29.71%-62.11% 9.25Cr
-1.41%-0.49%-40.46%-48.25% 6.28Cr
Average +0.68%-1.30%-14.90%+24.70% 15.89Cr
Weighted average by Cap. +0.47%-1.71%-3.85%+74.94%

Financials

2026 *2027 *
Net sales 35Cr 25Cr 22Cr 21Cr 19Cr 2.41TCr 35Cr 244.29Cr 94Cr 1.23TCr 95Cr 93Cr 3.87TCr 46Cr 33Cr 28Cr 27Cr 24Cr 3.15TCr 46Cr 319.94Cr 123.03Cr 1.6TCr 124.01Cr 121.29Cr 5.07TCr
Net income 13Cr 9.25Cr 7.97Cr 7.55Cr 6.84Cr 883.6Cr 13Cr 90Cr 34Cr 449.53Cr 35Cr 34Cr 1.42TCr 81L 58.39L 50.31L 47.63L 43.18L 56Cr 81.41L 5.66Cr 2.18Cr 28Cr 2.19Cr 2.14Cr 90Cr
Net Debt - -
Logo OrganiGram
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!